CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) is characterized by poor prognosis and a high frequency of central nervous system relapse after standard immunochemotherapy. We conducted a phase II study to investigate the efficacy and safe...
Kusumoto S   Tanaka S   Suzuki R   Watanabe T   Nakata M   Takasaki H   Fukushima N   Fukushima T   Moriuchi Y   Itoh K   Nosaka K   Choi I   Sawa M   Okamoto R   Tsujimura H   Uchida T   Suzuki S   Okamoto M   Takahashi T   Sugiura I   Onishi Y   Kohri M   Yoshida S   Sakai R   Kojima M   Takahashi M   Tomita A   Maruyama D   Atsuta Y   Tanaka E   Suzuki T   Kinoshita T   Ogura M   Mizokami M   Ueda R   
54th annual meeting of the American Society of Hematology 2012年12月
Kato H   Karube K   Yamamoto K   Takizawa J   Tsuzuki S   Katayama M   Kanda T   Yatabe Y   Ozawa Y   Ishitsuka K   Okamoto M   Kinoshita T   Oshima K   Nakamura S   Morishima Y   Seto M   
Okamoto A   Yanada M   Inaguma Y   Tokuda M   Morishima S   Kanie T   Yamamoto Y   Tuzuki M   Akatsuka Y   Mizuta S   Okamoto M   Emi N